Equi-Jec WNV

West Nile Virus Vaccine

Killed Virus

For use in animals only

This product has been shown to be effective for the vaccination of healthy horses 4 months of age or older, including pregnant mares, against West Nile Virus (WNV). The duration of immunity is at least 12 months. For more information regarding efficacy and safety data go to productdata.aphis.usda.gov.

This product has also been shown to be effective against viremia, mortality, and neurologic clinical disease due to WNV.

Directions and dosage: Shake well before use. Using aseptic technique, vaccinate horses intramuscularly with a 1 mL dose. Administer a second 1 mL dose intramuscularly in 3 to 4 weeks using a different injection site. The need for annual booster vaccinations has not been established for this product; consultation with a veterinarian or the manufacturer is recommended.

Precautions

Store at 35-46°F (2-8°C). Do not freeze. Do not mix with other products. Do not vaccinate within 21 days before slaughter. In case of anaphylactoid reaction, administer epinephrine. In case of human exposure, contact a physician.

Preservatives: Amphotericin B and gentamicin.

Equi-Jec^® is a registered trademark of Boehringer Ingelheim Vetmedica GmbH. Used under license.

US Patent Nos. 8,697,089; 8,821,889; and 9,517,259.

Manufactured/Distributed by:

Boehringer Ingelheim Animal Health USA Inc., St. Joseph, MO 64506

Phone: 1 (888) 637-4251

VLN/PCN 124/1995.21

1 Dose/1 mL

135415-02

CPN: 1028311.1